The associations between high-density lipoprotein mean particle size and its fatty acid composition

Biomarkers in Medicine

Volumn 7, Issue 2, 2013, Pages 235-245

  Emami Razavi, Amirnader ^a   Pourfarzam, Morteza ^a   Ani, Mohsen ^a   Naderi, Gholam Ali ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

anthropometric indices; dynamic light scattering; gas chromatography; high density lipoprotein fatty acid composition; high density lipoprotein size

Indexed keywords

ARACHIDONIC ACID; DIHOMOGAMALINOLEIC ACID; FATTY ACID; HIGH DENSITY LIPOPROTEIN; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; SATURATED FATTY ACID; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LIGHT SCATTERING; LIPID COMPOSITION; MALE; NORMAL HUMAN; PARTICLE SIZE;

ADULT; CHROMATOGRAPHY, GAS; FATTY ACIDS; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PARTICLE SIZE; YOUNG ADULT;

EID: 84875835264     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.12.115     Document Type: Article

References (55)

1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am. J. Med. 62(5), 707-714 (1977). (Pubitemid 8110784)
2. Manninen V, Tenkanen L, Koskinen P et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 85(1), 37-45 (1992).
3. Maron DJ. The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. Am. J. Cardiol. 86(12), 11-14 (2000).
4. Kwiterovich PO Jr. Lipoprotein heterogeneity: diagnostic and therapeutic implications. Am. J. Cardiol. 90(8A), 1i-10i (2002). (Pubitemid 35284906)
5. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18(7), 1046-1053 (1998). (Pubitemid 28323588)
6. Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23(10), 1881-1888 (2003). (Pubitemid 37254879)
7. Sakuma N, Yoshikawa M, Hibino T et al. HDL3 exerts a more powerful antiperoxidative and protective effect against peroxidative modification of LDL than HDL2 does. J. Nutr. Sci. Vitaminol. (Tokyo) 48(4), 278-282 (2002). (Pubitemid 35333981)
8. Yoshikawa M, Sakuma N, Hibino T, Sato T, Fujinami T. HDL3 exerts more powerful antioxidative, protective effects against copper-catalyzed LDL oxidation than HDL2. Clin. Biochem. 30(3), 221-225 (1997). (Pubitemid 27225355)
9. Chen MF, Wang TD, Yeh HT, Hsu HC, Lee YT. Gemfibrozil treatment potentiates oxidative resistance of high-density lipoprotein in hypertriglyceridemic patients. Eur. J. Clin. Invest. 31(8), 707-713 (2001).
10. Rise P, Eligini S, Ghezzi S, Colli S, Galli C. Fatty acid composition of plasma, blood cells and whole blood: relevance for the assessment of the fatty acid status in humans. Prostaglandins Leukot. Essent. Fatty Acids 76(6), 363-369 (2007). (Pubitemid 47095278)
11. Rye KA, Duong M, Psaltis MK et al. Evidence that phospholipids play a key role in pre-b ApoA-I formation and high-density lipoprotein remodeling. Biochemistry 41(41), 12538-12545 (2002).
12. Baker PW, Rye KA, Gamble JR, Vadas MA, Barter PJ. Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. J. Lipid Res. 41(8), 1261-1267 (2000). (Pubitemid 30666892)
13. Esteva O, Baudet MF, Lasserre M, Jacotot B. Influence of the fatty acid composition of high-density lipoprotein phospholipids on the cholesterol efflux from cultured fibroblasts. Biochim. Biophys. Acta 875(2), 174-182 (1986). (Pubitemid 16149039)
14. Tremblay AJ, Despres JP, Piche ME et al. Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome. Metabolism 53(3), 310-317 (2004). (Pubitemid 38684690)
15. Wang L, Folsom AR, Eckfeldt JH. Plasma fatty acid composition and incidence of coronary heart disease in middle aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Nutr. Metab. Cardiovasc. Dis. 13(5), 256-266 (2003). (Pubitemid 38622729)
16. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr. 78(1), 91-98 (2003). (Pubitemid 39655252)
17. Garcia-Palmieri MR, Sorlie P, Tillotson J, Costas R Jr, Cordero E, Rodriguez M. Relationship of dietary intake to subsequent coronary heart disease incidence: The Puerto Rico Heart Health Program. Am. J. Clin. Nutr. 33(8), 1818-1827 (1980). (Pubitemid 11215391)
18. Goldbourt U, Yaari S, Medalie JH. Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study. Cardiology 82(2-3), 100-121 (1993). (Pubitemid 23182022)
19. Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M, Willett WC. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 313(7049), 84-90 (1996). (Pubitemid 26257758)
20. Pietinen P, Ascherio A, Korhonen P et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The a-Tocopherol, b-Carotene Cancer Prevention Study. Am. J. Epidemiol. 145(10), 876-887 (1997). (Pubitemid 27200774)
21. Posner BM. On the importance of dietary fat. Conclusions from the Framingham Study. Acta Cardiol. 48(5), 452-455 (1993).
22. Gordon T, Kagan A, Garcia-Palmieri M et al. Diet and its relation to coronary heart disease and death in three populations. Circulation 63(3), 500-515 (1981). (Pubitemid 11139857)
23. Hu FB, Stampfer MJ, Manson JE et al. Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med. 337(21), 1491-1499 (1997). (Pubitemid 27495774)
24. Bronzert TJ, Brewer HB Jr. New micromethod for measuring cholesterol in plasma lipoprotein fractions. Clin. Chem. 23(11), 2089-2098 (1977). (Pubitemid 8220651)
25. Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87(1), 206-210 (1978). (Pubitemid 9050428)
26. Rawle A. PCS in 30 minutes. Malvern Instruments Inc. Malvern, UK, 1-8 (1995).
27. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226(1), 497-509 (1957).
28. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J. Lipid Res. 5, 600-608 (1964).
29. Ma J, Folsom AR, Shahar E, Eckfeldt JH. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am. J. Clin. Nutr. 62(3), 564-571 (1995).
30. Zock PL, Mensink RP, Harryvan J, de Vries JH, Katan MB. Fatty acids in serum cholesteryl esters as quantitative biomarkers of dietary intake in humans. Am. J. Epidemiol. 145(12), 1114-1122 (1997). (Pubitemid 27272941)
31. Miettinen TA, Naukkarinen V, Huttunen JK, Mattila S, Ku'in T. Fatty-acid composition of serum lipids predicts myocardial infarction. Br. Med. J. (Clin. Res. Ed.) 285(6347), 993-996 (1982). (Pubitemid 12018483)
32. Noori M, Darabi M, Rahimipour A, Rahbani M, Abadi NA, Ghatrehsamani K. Fatty acid composition of HDL phospholipids and coronary artery disease. J. Clin. Lipidol. 3(1), 39-44 (2009).
33. Gilmore LA, Walzem RL, Crouse SF et al. Consumption of high-oleic acid ground beef increases HDL-cholesterol concentration but both high-and low-oleic acid ground beef decrease HDL particle diameter in normocholesterolemic men. J. Nutr. 141(6), 1188-1194 (2011).
34. Ferrucci L, Cherubini A, Bandinelli S et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J. Clin. Endocrinol. Metab. 91(2), 439-446 (2006). (Pubitemid 43236907)
35. Weldon SM, Mullen AC, Loscher CE, Hurley LA, Roche HM. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J. Nutr. Biochem. 18(4), 250-258 (2007). (Pubitemid 46389578)
36. Zhao G, Etherton TD, Martin KR et al. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem. Biophys. Res. Commun. 336(3), 909-917 (2005). (Pubitemid 41338355)
37. Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J. Am. Coll. Nutr. 20(1), 5-19 (2001). (Pubitemid 32244959)
38. Wooten JS, Biggerstaff KD, Ben-Ezra V. Responses of LDL and HDL particle size and distribution to w-3 fatty acid supplementation and aerobic exercise. J. Appl. Physiol. 107(3), 794-800 (2009).
39. Bogl LH, Maranghi M, Rissanen A, Kaprio J, Taskinen MR, Pietiläinen KH. Dietary w-3 polyunsaturated fatty acid intake is related to a protective high-density lipoprotein subspecies profile independent of genetic effects: a monozygotic twin pair study. Atherosclerosis 219(2), 880-886 (2011).
40. Berglund L, Oliver EH, Fontanez N et al. HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects. Am. J. Clin. Nutr. 70(6), 992-1000 (1999).
41. Griffin BA. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr. Opin. Lipidol. 19(1), 57-62 (2008).
42. Harris WS, Assaad B, Poston WC. Tissue w-6/w-3 fatty acid ratio and risk for coronary artery disease. Am. J. Cardiol. 98(4), 19-26 (2006). (Pubitemid 44223361)
43. Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am. J. Clin. Nutr. 83(6), S1483-S1493 (2006).
44. Okuyama H, Ichikawa Y, Sun Y, Hamazaki T, Lands W. w3 fatty acids effectively prevent coronary heart disease and other late-onset diseases-the excessive linoleic acid syndrome. 96, 83-103 (2007).
45. Simopoulos A. Importance of the ratio of w-6/w-3 essential fatty acids: evolutionary aspects. World Rev. Nutr. Dietet. 92, 1-22 (2003).
46. Simopoulos AP. The importance of the ratio of w-6/w-3 essential fatty acids. Biomed. Pharmacother. 56(8), 365-379 (2002). (Pubitemid 35232740)
47. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83(6), S1505-S1519 (2006).
48. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97(20), 2007-2011 (1998). (Pubitemid 28243661)
49. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis. JAMA 285(19), 2481-2485 (2001).
50. Mackey RH, Greenland P, Goff DC, Lloyd-Jones D, Sibley CT, Mora S. High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). J. Am. Coll. Cardiol. 60(6), 508-516 (2012).
51. Sorli JV, Corella D, Frances F et al. The effect of the APOE polymorphism on HDL-C concentrations depends on the cholesterol ester transfer protein gene variation in a southern European population. Clin. Chim. Acta 366(1), 196-203 (2006). (Pubitemid 43330983)
52. Laporte R, Valvo-Gerard L, Kuller L et al. The relationship between alcohol consumption, liver enzymes and high-density lipoprotein cholesterol. Circulation 64(3 Pt 2), III 67-72 (1981). (Pubitemid 12224307)
53. Fossati P, Romon-Rousseaux M. Insulin and HDL-cholesterol metabolism. Diabete Metab. 13(3 Pt 2), 390-394 (1987). (Pubitemid 17105105)
54. O'Neal D, Harrip P, Dragicevic G, Rae D, Best JD. A comparison of LDL size determination using gradient gel electrophoresis and light-scattering methods. J. Lipid Res. 39(10), 2086-2090 (1998). (Pubitemid 28462366)
55. Lima ES, Maranhao RC. Rapid, simple laser-light-scattering method for HDL particle sizing in whole plasma. Clin. Chem. 50(6), 1086-1088 (2004). (Pubitemid 38725806)